Corteva AgriscienceÔäó, Agriculture Division of DowDuPont, and Monsanto Company Reach Licensing Agreement on Next-Generation Corn Insect Control Technology

Agreement Expands Options for North American Farmers, Reinforces
Both CompaniesÔÇÖ Commitment to Drive Agricultural Productivity through
Compelling Choices

ST. LOUIS & WILMINGTON, Del.–(BUSINESS WIRE)–Corteva AgriscienceÔäó, Agriculture Division of DowDuPont (NYSE: DWDP),
and Monsanto Company (NYSE: MON) announced today the completion of a
licensing agreement for next-generation technology for insect control in
corn for the U.S. and Canada that will expand options for farmers
fighting corn rootworm, dubbed the ÔÇ£billion dollar bugÔÇØ for the damage
it causes. Corteva AgriscienceÔäó will receive a license to stack
MonsantoÔÇÖs Corn Rootworm III and MON89034 traits with Corteva
AgriscienceÔÇÖs insect control traits. This agreement enables the
development of the next generation of insect control technology for
above- and below-ground insect pests, and will be offered with the
Enlist® herbicide tolerant trait for corn. Financial details of the
agreement are not being disclosed.

ÔÇ£This collaboration demonstrates the commitment Corteva AgriscienceÔäó has
to bringing greater choice to growers, helping them increase their
productivity and profitability,ÔÇØ said Tony Klemm, Global Corn Portfolio
Leader, Corteva AgriscienceÔäó, Agriculture Division of DowDuPont. ÔÇ£The
combination of Corn Rootworm III with Corteva AgriscienceÔÇÖs molecular
stack for insect control and the Enlist® corn trait will give our
customers the ability to protect yield while extending the durability of
industry-leading insect trait technology.ÔÇØ

MonsantoÔÇÖs broad licensing approach continues to put valuable,
cost-effective tools into the hands of farmers when they need them
most,ÔÇØ said Calvin Treat, MonsantoÔÇÖs Global Soy and Corn Technology
Lead. ÔÇ£We view this agreement as an endorsement for the novel mode of
action that MonsantoÔÇÖs Corn Rootworm III trait brings to farmers, as it
builds on the current products planted today by adding a new RNAi mode
of action that enhances effectiveness against one of the industryÔÇÖs most
destructive insect pests. Corn Rootworm III offers increased control and
additional durability against the corn rootworm by providing three
distinct methods of protection. Through the use of RNAi weÔÇÖre able to
target and control rootworms with a novel mode of action thatÔÇÖs
different than the Bt class of proteins that is used in other
insect-control products.ÔÇØ

This new next generation product combines Corteva AgriscienceÔÇÖs
molecular stack for insect control and Enlist┬« with MonsantoÔÇÖs Corn
Rootworm III and MON89034 (Bt) to create a broad-spectrum insect control
product with multiple modes of action for above- and below-ground pests.
Pending applicable regulatory reviews, it will be offered with the
Enlist® tolerant trait for corn, which provides tolerance to new 2,4-D
choline, and FOP herbicides in addition to the base glyphosate
tolerance. This brings additional benefits to farmers, offering more
weed control options and greater flexibility.

About Monsanto Company

Monsanto is committed to bringing a broad range of solutions to help
nourish our growing world. We produce seeds for fruits, vegetables and
key crops – such as corn, soybeans, and cotton – that help farmers have
better harvests while using water and other important resources more
efficiently. We work to find sustainable solutions for soil health, help
farmers use data to improve farming practices and conserve natural
resources, and provide crop protection products to minimize damage from
pests and disease. Through programs and partnerships, we collaborate
with farmers, researchers, nonprofit organizations, universities and
others to help tackle some of the worldÔÇÖs biggest challenges. To learn
more about Monsanto, our commitments and our more than 20,000 dedicated
employees, please visit monsanto.com. Follow
our business on Twitter® at twitter.com/MonsantoCo.

About Corteva AgriscienceÔäó, Agriculture
Division of DowDuPont

Corteva AgriscienceÔäó, Agriculture Division of DowDuPont
(NYSE: DWDP), is intended to become an independent, publicly traded
company when the previously
announced spinoff is complete by June 2019. The division combines
the strengths of DuPont Pioneer, DuPont Crop Protection and Dow
AgroSciences. Corteva AgriscienceÔäó provides growers around
the world with the most complete portfolio in the industry ÔÇö including
some of the most recognized brands in agriculture: Pioneer®,
Encirca┬«, the newly launched BrevantÔäó Seeds, as
well as award-winning Crop Protection products ÔÇö while bringing new
products to market through our solid pipeline of active chemistry and
technologies. More information can be found at www.corteva.com.
Follow Corteva AgriscienceÔäó, Agriculture Division of DowDuPont, on Facebook,
Instagram,
LinkedIn,
Twitter
and YouTube.

About DowDuPont

DowDuPont (NYSE: DWDP) is a holding company comprised of The Dow
Chemical Company and DuPont with the intent to form strong, independent,
publicly traded companies in agriculture, materials science and
specialty products sectors that will lead their respective industries
through productive, science-based innovation to meet the needs of
customers and help solve global challenges. For more information, please
visit us at www.dow-dupont.com.

Follow Corteva AgriscienceÔäó, Agriculture Division of DowDuPont, on Facebook,
Instagram,
LinkedIn,
Twitter
and YouTube.

Cautionary Statements Regarding
Forward-Looking Information:

Certain statements contained in this release are ÔÇ£forward-looking
statements,ÔÇØ such as statements concerning the companyÔÇÖs anticipated
financial results, current and future product performance, regulatory
approvals, business and financial plans and other non-historical facts,
as well as the pending transaction with Bayer Aktiengesellschaft
(ÔÇ£BayerÔÇØ). These statements are based on current expectations and
currently available information. However, since these statements are
based on factors that involve risks and uncertainties, the companyÔÇÖs
actual performance and results may differ materially from those
described or implied by such forward-looking statements. Factors that
could cause or contribute to such differences include, among others:
risks related to the pending transaction between the company and Bayer,
including the risk that the regulatory approvals required for the
transaction may not be obtained on the anticipated terms or time frame
or at all, the risk that the other conditions to the completion of the
transaction may not be satisfied, the risk that disruptions or
uncertainties related to the pending transaction could adversely affect
the companyÔÇÖs business, financial performance and/or relationships with
third parties, and the risk that certain contractual restrictions during
the pendency of the transaction could adversely affect the companyÔÇÖs
ability to pursue business opportunities or strategic transactions;
continued competition in seeds, traits and agricultural chemicals; the
company's exposure to various contingencies, including those related to
intellectual property protection, regulatory compliance and the speed
with which approvals are received, and public understanding and
acceptance of our biotechnology and other agricultural products; the
success of the company's research and development activities; the
outcomes of major lawsuits, including potential litigation related to
the pending transaction with Bayer; developments related to foreign
currencies and economies; fluctuations in commodity prices; compliance
with regulations affecting our manufacturing; the accuracy of the
company's estimates related to distribution inventory levels; the levels
of indebtedness, continued availability of capital and financing and
rating agency actions; the company's ability to fund its short-term
financing needs and to obtain payment for the products that it sells;
the effect of weather conditions, natural disasters, accidents, and
security breaches, including cybersecurity incidents, on the agriculture
business or the company's facilities; and other risks and factors
detailed in the company's most recent periodic report to the SEC. Undue
reliance should not be placed on these forward-looking statements, which
are current only as of the date of this release. The company disclaims
any current intention or obligation to update any forward-looking
statements or any of the factors that may affect actual results.

NOTE TO EDITORS: All products, unless otherwise noted, denoted with Ôäó, Ôäá
or ® are trademarks or registered trademarks of their respective
companies.

Contacts

Monsanto
Christi Dixon, 314-694-1092
or
DuPont
Gregg
M. Schmidt, 302-996-8368